Peptides Being Studied for Mental Health Some peptides that have generated discussion include: Semax researched for cognitive function and neuroprotection Selank studied for anxiolytic (anti-anxiety) effects BPC-157 investigated for its potential anti-inflammatory properties Thymosin Beta-4 associated with tissue repair and systemic healing It is important to note that research is ongoing, and many peptide therapies are not FDA-approved specifically for mental health treatment
Other studies using rodents or primates with immunofluorescent reporter GLP-1Rs verify the expression of GLP-1Rs by pyramidal (glutamergic), GABAergic and catecholaminergic neurons in feeding, energy homeostasis, fear, stress, motivation/reward, learning plus memory as well as Alzheimers disease (AD) and Parkinsons Disease (PD)-associated key brain areas, such as the hippocampus, hypothalamus, cortex, striatum, amygdala, SNpc, or ventral tegmental area (VTA) (Cork et al., 2015
Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents
One of the Ryblesus pills is due to be renamed the Ozempic Pill